Dr. Stephanie LeValley is an Associate Program Officer for Helmsley’s Crohn’s Disease Program. In this role, Stephanie supports the Disease Biology portfolio of grants aiming to uncover the underlying mechanisms of disease initiation and progression, as well as the development of complications, to inform therapeutic and diagnostic approaches. In addition, Stephanie serves as the Program Lead for the Gut Cell Atlas, a consortium of grants cataloguing the cell types in the small and large intestine in Crohn’s disease patients.

Prior to joining Helmsley, Stephanie performed research on the interactions between the microbiome and hormone-producing enteroendocrine cells in the gastrointestinal tract, with a focus on diagnostic and therapeutic applications for metabolic disease.

Stephanie earned her Ph.D. in Molecular Virology and Microbiology from Baylor College of Medicine in Houston, Texas, and a Bachelor of Science from Michigan State University. Previous research experiences include working with flies, worms, and mosquitoes!